Cargando…

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients

INTRODUCTION: The aim of this study was to evaluate the safety and efficacy of rituximab (RTX) in a large cohort of patients with rheumatoid arthritis in routine care, and to monitor changes in daily practice since the introduction of RTX therapy. METHODS: This was a multicentre, prospective, non-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wendler, Joerg, Burmester, Gerd R, Sörensen, Helmut, Krause, Andreas, Richter, Constanze, Tony, Hans-Peter, Rubbert-Roth, Andrea, Bartz-Bazzanella, Peter, Wassenberg, Siegfried, Haug-Rost, Iris, Dörner, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060207/ https://www.ncbi.nlm.nih.gov/pubmed/24670196 http://dx.doi.org/10.1186/ar4521

Ejemplares similares

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
por: Behrens, Frank, et al.
Publicado: (2021)

Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
por: Koehm, Michaela, et al.
Publicado: (2022)

Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany
por: Krüger, Klaus, et al.
Publicado: (2020)

Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
por: Krüger, Klaus, et al.
Publicado: (2018)

Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
por: Krüger, Klaus, et al.
Publicado: (2018)

Successful Treatment of Rituximab-Associated Palmoplantar Pustulosis With Apremilast in a Patient With Seropositive Rheumatoid Arthritis
por: Haller, Christoph, et al.
Publicado: (2021)

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
por: Tony, Hans-Peter, et al.
Publicado: (2011)

2484. Pre-Transplant Vaccination Adherence in Pediatric Solid Organ Transplant Patients at a Large Academic Medical Center
por: Fela, Eric, et al.
Publicado: (2018)

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
por: Burmester, Gerd R, et al.
Publicado: (2010)

2484. Clinical and genomic comparison of nosocomial-onset and community-onset listeriosis: a nationwide retrospective study in Japan, 2011-2021
por: Shinohara, Koh, et al.
Publicado: (2023)

Kitasato symposium 2011: translational prospects for cytokines
por: Burmester, Gerd R, et al.
Publicado: (2011)

Kitasato symposium 2010: new prospects for cytokines
por: Burmester, Gerd R, et al.
Publicado: (2010)

Kitasato Symposium 2009: New Prospects for Cytokine Inhibition
por: Burmester, Gerd R, et al.
Publicado: (2009)

In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer
por: Stengel, C, et al.
Publicado: (2014)

2484: Establishment of the Tennessee-sickle cell disease network as a mechanism for engaging a rare disease population in patient centered outcomes research
por: Mayo-Gamble, Tilicia, et al.
Publicado: (2018)

Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
por: Kleinert, Stefan, et al.
Publicado: (2011)

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trial
por: Detert, Jacqueline, et al.
Publicado: (2014)

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice
por: Backhaus, Marina, et al.
Publicado: (2015)

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2011)

484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012)

MON-484 Thyroid Nodules: Not so Simple to Manage
por: Cruz, Alegyari Figueroa, et al.
Publicado: (2020)

Emergence of OXA-484-Producing Klebsiella variicola in China
por: Ge, Haoyu, et al.
Publicado: (2023)

Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab
por: Rubbert-Roth, Andrea, et al.
Publicado: (2022)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
por: Lindenberg, Luisa, et al.
Publicado: (2015)

Correction: Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2008)

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2006)

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
por: Burmester, Gerd R, et al.
Publicado: (2017)

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
por: Burmester, Gerd R, et al.
Publicado: (2016)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

2484. Patient Reported Outcomes After Switching to a 2-Drug Regimen of Dolutegravir + Rilpivirine: Week 148 Results from the Sword-1 and Sword-2 Studies
por: Oglesby, Alan, et al.
Publicado: (2019)

Correction: Chalivendra et al. Effect of Shear Angle and Printing Orientation on Shear Constitutive Response of Additively Manufactured Acrylonitrile Butadiene Styrene. Polymers 2022, 14, 2484
por: Letizia, Joshua, et al.
Publicado: (2022)

SUN-484 Complex Thyroid Cancer with Several Recurrences and Metastases
por: Patel, Kruti K, et al.
Publicado: (2020)

miR-484: A Potential Biomarker in Health and Disease
por: Jia, Yin-zhao, et al.
Publicado: (2022)

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus
por: Henneken, Maren, et al.
Publicado: (2005)

Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis
por: Smith, Michael F, et al.
Publicado: (2009)

PB2484: IMMUNE PRIVILEGES OF NESTIN-GFP+ CELLS OF THE BONE MARROW ARE PRESERVED IN IMMUNOLOGICALLY COMPLETE IMMUNIZED WITH GFP MICE IN THE MODEL OF ECTOPIC FOCI OF HEMATOPOIESIS UNDER THE RENAL CAPSULE
por: Karpenko, Dmitriy, et al.
Publicado: (2023)

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study—a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
por: Kedor, Claudia, et al.
Publicado: (2021)

OXA-484, an OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamase From Escherichia coli
por: Sommer, Julian, et al.
Publicado: (2021)

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
por: Rubbert-Roth, Andrea, et al.
Publicado: (2010)

E484K as an innovative phylogenetic event for viral evolution: Genomic analysis of the E484K spike mutation in SARS-CoV-2 lineages from Brazil
por: Ferrareze, Patrícia Aline Gröhs, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vu6ces704etoldhnv7s5d0vum8